Technology | Treatment Planning | December 19, 2017

New release includes support for upcoming RayCare oncology information system integration and Mevion Hyperscan proton therapy technology

RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System

December 19, 2017 — RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and a wide range of improvements. Significant additions include support for Hyperscan technology from Mevion Medical Systems, and integration with RayCare, the next-generation oncology information system (OIS) shortly to be launched by RaySearch.

The functionality additions in the new release are intended to unify treatment planning for as many systems as possible, eliminating the complications and additional steps that arise from using multiple software systems. This release also contains several enhancements to existing functionality that will contribute to improved workflows and planning efficiency.

RayStation 7 contains some significant new features for proton therapy treatment planning. A key inclusion is support for Mevion’s Hyperscan pencil beam scanning (PBS) technology. In addition, RayStation now supports uniform scanning for proton therapy systems from Mitsubishi Electric. Other proton therapy improvements include snout rotation for passive proton techniques and MLC collimation for PBS and passive techniques.

Further key refinements to RayStation functionality include the addition of robust constraints in MCO, simulated organ motion for robust optimization and evaluation, multi-atlas-based segmentation and conformal arc planning for photons.

Later this December, RaySearch will launch the new RayCare OIS, which will integrate fully with RayStation. The new RayStation 7 release includes functionality to ensure a seamless experience for users of the combined systems.

For more information: www.raysearchlabs.com


Related Content

News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Subscribe Now